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Abstract
Background: To reduce inappropriate antibiotic use, public health campaigns often provide fear-based information
about antimicrobial resistance (AMR). Meta-analyses have found that fear-based campaigns in other contexts are
likely to be ineffective unless respondents feel confident they can carry out the recommended behaviour (‘self-
efficacy’). This study aimed to test the likely impact of fear-based messages, with and without empowering self-
efficacy elements, on patient consultations/antibiotic requests for influenza-like illnesses, using a randomised design.
Methods: We hypothesised that fear-based messages containing empowering information about self-management
without antibiotics would be more effective than fear alone, particularly in a pre-specified subgroup with low AMR
awareness. Four thousand respondents from an online panel, representative of UK adults, were randomised to
receive three different messages about antibiotic use and AMR, designed to induce fear about AMR to varying
degrees. Two messages (one ‘strong-fear’, one ‘mild-fear’) also contained empowering information regarding
influenza-like symptoms being easily self-managed without antibiotics. The main outcome measures were self-
reported effect of information on likelihood of visiting a doctor and requesting antibiotics, for influenza-like illness,
analysed separately according to whether or not the AMR information was ‘very/somewhat new’ to respondents,
pre-specified based on a previous (non-randomised) survey.
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Results: The ‘fear-only’ message was ‘very/somewhat new’ to 285/1000 (28.5%) respondents, ‘mild-fear-plus-
empowerment’ to 336/1500 (22.4%), and ‘strong-fear-plus-empowerment’ to 388/1500 (25.9%) (p = 0.002). Of those for
whom the respective information was ‘very/somewhat new’, only those given the ‘strong-fear-plus-empowerment’
message said they would be less likely to request antibiotics if they visited a doctor for an influenza-like illness (p <
0.0001; 182/388 (46.9%) ‘much less likely’/‘less likely’, versus 116/336 (34.5%) with ‘mild-fear-plus-empowerment’ versus
85/285 (29.8%) with ‘fear-alone’). Those for whom the respective information was not ‘very/somewhat new’ said they
would be less likely to request antibiotics for influenza-like illness (p < 0.0001) across all messages (interaction p < 0.0001
versus ‘very/somewhat new’ subgroup). The three messages had analogous self-reported effects on likelihood of
visiting a doctor and in subgroups defined by believing antibiotics would ‘definitely/probably’ help an influenza-like
illness. Results were reproduced in an independent randomised survey (additional 4000 adults).
Conclusions: Fear could be effective in public campaigns to reduce inappropriate antibiotic use, but should be
combined with messages empowering patients to self-manage symptoms effectively without antibiotics.
Keywords: Inappropriate antibiotic use, Fear messages about antimicrobial resistance, Public campaigns
Background
Antimicrobial resistance (AMR) is an increasingly ser-
ious threat to global public health [1], estimated to
account for 10 million deaths annually worldwide by
2050, and potentially imposing similar economic costs
as climate change [2, 3]. A recent European study
found that the burden of antibiotic-resistant infections
(excluding tuberculosis) in terms of disability-adjusted
life-years (DALYs) is similar to influenza, tuberculosis,
and HIV combined [4]. Strong links have been found
between the volume of human antibiotic consumption
and AMR [5–9]. Thus, better stewardship of existing
antibiotics, reducing inappropriate use without
compromising essential access, is crucial to control
AMR [3, 10–13].
Respiratory tract infections (RTIs) account for around
50% of antibiotic prescribing in primary care [14], much
of which fails to benefit patients as the infections are
self-limiting or viral [15]. Antibiotic use for RTIs not
only affects resistance among possible causative bacterial
pathogens, but also drives resistance among commensal
flora, which can later cause resistant infections [9].
Differences in clinical consultation rates explain much
of the variation in non-hospital antibiotic usage in Eng-
land [16], and clinicians are more likely to prescribe an-
tibiotics when patients request them or are perceived to
want them [17–19]. Thus, in healthcare systems such as
that of the United Kingdom (UK), where general practi-
tioners act as gatekeepers to prescriptions, decisions
whether to consult, and whether to request antibiotics,
for RTIs could each play a significant role in ‘unneces-
sary’ antibiotic consumption. A review of public cam-
paigns [20] aimed at improving antibiotic use among
outpatients in high-income countries concluded that
several campaigns had a positive effect. However, nearly
all were multi-faceted, simultaneously targeting physi-
cians and the public with multiple interventions.
Therefore, it was difficult to unpick whether improve-
ments were due to changes in the behaviour of patients,
physicians, or both or whether the observed improve-
ments were related to confounding factors which would
have happened without the campaigns. All campaigns in
the review tried to convey the message that AMR is a
serious problem, sometimes using a fear message. Most
also tried to educate the public that antibiotics are often
ineffective for RTIs.
However, in other healthcare areas, meta-analyses
have found that while such ‘fear-appeal’ messages can
be effective, they are likely to be ineffective and may
even backfire if people are not confident that they
will be able to successfully take the recommended ac-
tion (‘self-efficacy’) or that the recommended action
will be effective (‘response-efficacy’) [21–23]. In a pre-
vious survey [24], we found that an AMR ‘fear mes-
sage’, which contained no information about how to
successfully manage influenza-like illness (ILI) symp-
toms (generally not requiring antibiotics), was likely
to backfire among those with low AMR awareness:
paradoxically, significantly more of these respondents
said they would be more likely, rather than less likely,
to ask a doctor for antibiotics for ILI given the infor-
mation. We hypothesised that fear-based messages
also containing empowering information about suc-
cessful self-management without antibiotics would be
more effective, particularly among those with low
AMR awareness, who we hypothesised would respond
less favourably than others to fear-based messages in
general. We therefore developed an experiment to test
several AMR ‘fear messages’, with and without
empowering content intended to provide confidence
that ILI symptoms can be successfully self-managed
without antibiotics. The aim was to identify the form
of words most likely to discourage people from asking
for antibiotics for ILI, particularly among those with
Roope et al. BMC Medicine          (2020) 18:110 Page 2 of 11
low AMR awareness (pre-specified based on our pre-
vious survey) and those who believe antibiotics are ef-
fective for ILI (exploratory analysis).
Methods
The randomised experiment was conducted using an on-
line survey of adult members of the UK general public,
in two waves. Wave 2 was conducted as a validation
study, using identical methods but analysed separately
on an independent sample, after analysing data from
wave 1.
Survey design
The survey (Additional file 1) asked respondents to im-
agine Health State A: ‘a temperature, aching muscles, a
headache, a dry chesty cough, a sore throat, and you feel
weak’, representing, and hereafter referred to as, ILI. A
symptomatic description was used, rather than specify-
ing ‘flu’ or a ‘virus’, firstly, because individuals are likely
to interpret specific terms differently, and secondly, be-
cause people may know that antibiotics are not indicated
for viral conditions, yet not recognise ILI symptoms as
being more consistent with a viral, than bacterial,
infection.
Respondents were randomised to receive one of
three different messages about antibiotics and AMR
(Table 1). In each wave, N = 1000 received version 1,
a ‘fear message’ about the dangers of AMR, and AMR
being caused by inappropriate antibiotic use. Two
other groups (both N = 1500 in each wave) also re-
ceived a ‘fear message’ but together with empowering
information that ILI symptoms can easily and effect-
ively be self-managed without antibiotics, differing
only by the strength of the ‘fear message’ (stronger
fear level in version 3 than the relatively mild version
2). Version 1 was a slight variant of the ‘fear message’
previously found [24] to backfire among respondents
who found this AMR information surprising. Version
2 and version 3 were developed based on health-
psychological theory, incorporating empowering ‘self-
efficacy’ and ‘response-efficacy’ aspects to mitigate or
remove backfiring potential.
Respondents were then asked ‘To what extent is this
information new to you?’ [very new/somewhat new/not
very new/not at all new], ‘How will this information
affect whether you visit a doctor the next time you have
symptoms like Health State A?’ [much more likely to
visit/more likely to visit/no effect/less likely to visit/
much less likely to visit/do not know], and ‘How will this
information affect the likelihood of you asking a doctor
for antibiotics if you were to visit for these symptoms?’
[much more likely/more likely/no effect/less likely/much
less likely/do not know] (co-primary outcomes: likeli-
hood of visiting a doctor and of requesting antibiotics).
Table 1 Three versions of information about antibiotics and








Full text ‘Antibiotic resistance happens when an antibiotic
no longer kills or controls growing bacteria. It is an
increasingly serious threat to public health.
Without antibiotics that work well, many routine
treatments will become increasingly dangerous.
Setting broken bones, and even basic operations,
rely on access to antibiotics that work. Antibiotic
resistance is believed to be caused by unnecessary
use of antibiotics, and inappropriate use, such as
not taking them as prescribed, skipping doses, or








Full text ‘Most people get cold or flu symptoms every year,
and these usually get better on their own.
Temperatures sometimes last for days, while
coughs can last for weeks, and antibiotics
generally don't help. Antibiotics should not be
taken for cold and flu symptoms. Taking
antibiotics when they are not needed encourages
bacteria to become resistant. This means
antibiotics may not work for future serious
illnesses that can only be cured by antibiotics.
Most cold and flu symptoms are best treated at
home by taking paracetamol or ibuprofen, and








Full text ‘Most people get cold or flu symptoms every year,
and these usually get better on their own.
Temperatures sometimes last for days, while
coughs can last for weeks, and antibiotics
generally don't help. Antibiotics should not be
taken for cold and flu symptoms. Taking
antibiotics encourages bacteria to become
resistant. Some killer diseases are already resistant
to several antibiotics. Antibiotic resistance is an
increasingly serious threat to everyone’s health.
Soon we will not be able to find antibiotics that
can cure serious illnesses. Even worse, without
antibiotics that work, even minor injuries and
routine operations will become increasingly
dangerous. You can also pass on resistant bugs to
people you care about. Most cold and flu
symptoms are best treated at home by taking
paracetamol or ibuprofen, and getting plenty of
fluids and sleep.’
Roope et al. BMC Medicine          (2020) 18:110 Page 3 of 11
Respondents with children were additionally asked
analogous questions regarding how they would act if
their youngest child had ILI symptoms (secondary out-
comes in the subgroup with children).
Based on our previous survey [24], the impact of each
randomised message on all outcomes was considered sep-
arately by whether or not respondents said the AMR in-
formation was ‘very/somewhat new’, formally compared
using interaction tests. A limitation of comparing respon-
dents for whom information is ‘new’ across the three ver-
sions is that this may not compare like with like—for
example, some respondents might find version 3 ‘new’ but
not version 2. In exploratory analysis, the impacts of the
randomised messages were therefore also considered sep-
arately by whether or not respondents thought antibiotics
would ‘definitely/probably help’ an ILI which persisted for
5 days.
The survey captured information on socio-demographic
characteristics including age, sex, ethnicity, education,
employment status, geographic region, and having
dependent children. Both the original AMR message
(‘fear-only’) and the survey were designed with clinical
experts (n = 3; primary care physician and two junior
doctors) and a public and patient involvement panel
(n = 7). Amendments to the AMR message were de-
signed primarily by health psychologist authors on
this paper (STC, NH, SM, AS).
Survey respondents
Both survey waves were conducted online using re-
spondent panels provided by Survey Sampling Inter-
national (SSI). In each wave, SSI was commissioned
to obtain 4000 completed responses, representative of
the UK adult population in terms of sex, age, ethni-
city, and geographic region. Surveys were completed
over 17 days during October/November 2016 (wave 1)
and 22 days during March 2017 (wave 2). In wave 1,
invitations were emailed to 28,887 SSI panel mem-
bers; 8317 panel members were emailed in wave 2. It
was also possible for SSI panel members to access the
survey via SSI’s website. The two waves were com-
pletely independent, with no respondent overlap. Re-
spondents were offered an incentive to complete the
questionnaire in the form of ‘Nectar-points’ (a loyalty
card scheme via which customers accrue discounts at
outlets including supermarkets and restaurants), worth
a total of approximately £0.60. To mitigate self-
selection bias, specific project details were not in-
cluded in the invitation. In each wave, sample sizes
for groups receiving version 2 and version 3 were
powered to quantify the proportion of individuals
who, in response to the information, said they would
be ‘less/much less likely’ to visit a doctor the next
time they have ILI symptoms, at a 95% confidence
level, with a maximum margin of error of 2.5%.
Statistical analysis
Wilcoxon’s single-sample sign-rank tests were per-
formed to test whether respondents were more or less
likely to consult/request antibiotics for ILI in response
to the information, overall and within subgroups defined
by whether respondents said the information they were
given about AMR was ‘very/somewhat new’ (and, in ex-
ploratory analysis, by whether antibiotics would ‘defin-
itely/probably help’ an ILI). For each randomised
message, Wilcoxon’s rank-sum tests were used to ana-
lyse whether the distribution of responses differed sig-
nificantly between subgroups. Ordered logit regressions
were used to test for interactions between message treat-
ment effects and subgroups, with the extent of being
more/less likely to consult/request antibiotics the
dependent variables. All statistical analysis was con-
ducted using Stata MP v13.1.
Results
Four thousand individuals completed the survey in
October/November 2016, and another 4000 in March
2017. Baseline characteristics were broadly balanced
across randomised messages (Table 2, Additional file 2:
Table S1). As the two waves gave qualitatively very
similar results (Fig. 1, details in Additional file 2:
Tables S2, S3), we focus on the more-recent wave 2.
Reported response to information for respondents’ own
ILI
In wave 2, overall, 29.2%, 45.1%, and 46.1% of respondents
randomised to ‘fear-only’, ‘mild-fear-plus-empowerment’,
and ‘strong-fear-plus-empowerment’ respectively reported
that they would be ‘less/much less likely’ to visit a doctor as
a result of the information given (p < 0.0001), while 14.1%,
10.3%, and 11.3% reported that they would be ‘more/much
more likely’ to visit a doctor (p = 0.01) (Additional file 2:
Table S3). For requesting antibiotics, 42.3%, 52.5%, and
54.7% respectively reported that they would be ‘less/much
less likely’ to ask for antibiotics as a result of the informa-
tion (p < 0.0001), while 10.1%, 8.2%, and 7.5% respectively
reported that they would be ‘more/much more likely’ to ask
for antibiotics (p = 0.08) (Additional file 2: Table S3).
Overall, 25.2% of respondents said the information
they were randomised to was ‘very/somewhat new’,
with small but significant variation between messages
(p = 0.002, Table 2). Furthermore, 27.8% believed anti-
biotics would ‘definitely/probably’ help an ILI which
persisted for 5 days, with no evidence of variation be-
tween messages (p = 0.99, Table 2). As hypothesised,
respondents who found the information ‘very/some-
what new’ were less likely than the others to report
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that it would make them less likely to visit their
doctor or ask for antibiotics (both ‘visit’ and ‘ask’ in-
teractions p < 0.0001; Fig. 1a, b; Additional file 2:
Table S3). Similarly, respondents who thought anti-
biotics would ‘definitely/probably’ help ILI were less
likely than the others to report that it would make
them less likely to visit a doctor or ask for antibi-
otics (both ‘visit’ and ‘ask’ interactions p < 0.0001;
Fig. 2a, b; Additional file 2: Table S4; similar results
for wave 1, Additional file 2: Table S5).
Response to information for respondents’ own ILI:
information not ‘very/somewhat new’
Among those for whom the information was not
‘very/somewhat new’, significantly more respondents
said they would be less likely (rather than more
likely) to consult/request antibiotics for ILI in re-
sponse to each message (p < 0.0001; Fig. 1a, b), with
< 5% reporting that they would be more likely to visit
a doctor/request antibiotics regardless of message.
Similarly, of those who did not think antibiotics
Table 2 Respondent characteristics in wave 2 (March 2017)
Factor Version 1 (N = 1000): ‘fear-
only’
Version 2 (N = 1500): ‘mild-fear-plus-
empowerment’






Mean or number Standard deviation
or %
Mean or number Standard
deviation or %
Age 47.2 16.7 46.5 16.8 46.0 16.7
Household equivalent income (£)1 20,571 14,431 20,164 15,107 20,166 15,379
Own self-rated health (0–10) 7.2 2.0 7.3 2.0 7.3 2.0
Male1 502 50.3% 724 48.3% 715 47.7%
White1 899 90.3% 1352 90.6% 1355 91.0%
Christian1 486 49.6% 700 48.0% 672 45.7%
Higher education 448 44.8% 658 43.9% 650 43.3%
Unemployed 41 4.1% 74 4.9% 69 4.6%
Sick or disabled 38 3.8% 64 4.3% 60 4.0%
Married/civil partnership/live
with partner
674 67.4% 1015 67.7% 979 65.3%
Born in UK 906 90.6% 1351 90.1% 1347 89.8%
Geographic region
East Anglia 90 9.0% 138 9.2% 144 9.6%
East Midlands 62 6.2% 111 7.4% 117 7.8%
West Midlands 88 8.8% 121 8.1% 145 9.7%
London 129 12.9% 198 13.2% 189 12.6%
North East 42 4.2% 55 3.7% 7.1 4.7%
North West 116 11.6% 177 11.8% 157 10.5%
South East 149 14.9% 196 13.1% 206 13.7%
South West 96 9.6% 120 8.0% 127 8.5%
Yorkshire and Humberside 81 8.1% 121 8.1% 135 9.0%
Wales 46 4.6% 88 5.9% 63 4.2%
Scotland 77 7.7% 132 8.8% 109 7.3%
Northern Ireland 24 2.4% 43 2.9% 37 2.5%
AMR information is ‘very/
somewhat new’
285 28.5% 336 22.4% 388 25.9%
Antibiotics would ‘definitely/
probably’ help ILI
279 27.9% 415 27.7% 418 27.9%
Antibiotics would ‘definitely/
probably’ help child’s ILI
183/408 44.9% 255/587 43.4% 250/605 41.3%
1Version 1 denominator is 1000 except for household income (N = 940), gender (N = 999), ethnicity (N = 996), and religion (N = 979) where there was a ‘prefer not
to answer’ option; version 2 denominator is 1500 except for household income (N = 1360), gender (N = 1499), ethnicity (N = 1493), and religion (N = 1459) where
there was a ‘prefer not to answer’ option; version 3 denominator is 1500 except for household income (N = 1389), gender (N = 1498), ethnicity (N = 1489), and
religion (N = 1469) where there was a ‘prefer not to answer’ option
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A. Adult visiting doctor
Information “new”
B. Adult asking for antibiotics
Information “new”
C. Visiting doctor for child
Information “new”
D. Asking for antibiotics for child
Information “new”
Information “not new” Information “not new” Information “not new” Information “not new”
Wilcoxon single-sample sign-rank tests
Wave 1 Wave 2




V1 p<0.0001 p<0.0001 p<0.0001 p<0.0001
V2 p=0.01 p<0.0001 p=0.07 p<0.0001
V3 p=0.80 p<0.0001 p=0.85 p<0.0001
Wilcoxon single-sample sign-rank tests:
Wave 1 Wave 2
Info new Info 
not new
Info new Info 
not new
V1 p=0.04 p<0.0001 p=0.97 p<0.0001
V2 p=0.69 p<0.0001 p=0.19 p<0.0001
V3 p<0.0001 p<0.0001 p<0.0001 p<0.0001
Wilcoxon single-sample sign-rank tests:
Wave 1 Wave 2
Info new Info 
not new
Info new Info 
not new
V1 p<0.0001 p=0.01 p<0.0001 p=0.0002
V2 p<0.0001 p<0.0001 p<0.0001 p<0.0001
V3 p<0.0001 p<0.0001 p<0.0001 p<0.0001
Wilcoxon single-sample sign-rank tests:





V1 p=0.06 p<0.0001 p=0.05 p<0.0001
V2 p=0.02 p<0.0001 p=0.03 p<0.0001
V3 p=0.78 p<0.0001 p=0.30 p<0.0001
Fig. 1 Reported impact of information on consultations/antibiotic requests disaggregated according to whether AMR information ‘new’ vs ‘not
new’. (i) Prior Survey results are for May–June 2015 data reported in Roope et al. [24]; wave 1 conducted in October–November 2016; wave 2
conducted in March 2017. (ii) V1 is ‘fear-only’ message; V2 is ‘mild-fear-plus-empowerment’; V3 is ‘strong-fear-plus-empowerment’. (iii) Column
charts exclude respondents who answered ‘do not know’ (< 8%). (iv) p values are from Wilcoxon’s single-sample sign-rank tests of whether
respondents were more/less likely to consult/request antibiotics for ILI in response to the information they were given, under the null hypothesis
that they were neither more likely nor less likely to consult/request antibiotics
Fig. 2 Reported impact of information on consultations/antibiotic requests disaggregated by whether or not antibiotics would ‘help’ ILI. (i) Prior
Survey results are for May–June 2015 data reported in Roope et al. [24]; wave 1 conducted in October–November 2016; wave 2 conducted in
March 2017. (ii) V1 is ‘fear-only’ message; V2 is ‘mild-fear-plus-empowerment’; V3 is ‘strong-fear-plus-empowerment’. (iii) Column charts exclude
respondents who answered ‘do not know’ (< 7%). (iv) p values are from Wilcoxon’s single-sample sign-rank tests of whether respondents were
more/less likely to consult/request antibiotics for ILI in response to the information they were given, under the null hypothesis that they were
neither more likely nor less likely to consult/request antibiotics
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would help ILI, significantly more said they would be less
likely (rather than more likely) to consult/request antibi-
otics for ILI in response to each message (p < 0.0001;
Fig. 2a, b).
Response to information for respondents’ own ILI:
information ‘very/somewhat new’
In contrast to respondents for whom the information
was not ‘very/somewhat new’, among those for whom
the information was ‘very/somewhat new’, and exposed
to the ‘fear-only’ message, significantly more said they
were more likely (rather than less likely) to consult for
ILI (38.2% more likely versus 21.8% less likely; p =
0.0001, Fig. 1a). There was no significant difference be-
tween the proportion who said they would be more
likely (versus less likely) to request antibiotics (p = 0.97;
Fig. 1b). The results were similar for respondents ex-
posed to the ‘fear-only’ message who believed antibiotics
would ‘definitely/probably help’ (Fig. 2a, b), with 34.8%
saying they were more likely, versus 16.1% less likely, to
consult for ILI (p < 0.0001), and no significant difference
between the proportions who said they would be more
likely (versus less likely) to request antibiotics (p = 0.85).
However, those exposed to the ‘mild-fear-plus-em-
powerment’ message and who found the message ‘very/
somewhat new’ said they were no more/less likely to
consult for ILI (38.4% more likely versus 28.9% less
likely; p = 0.07) and no more/less likely to request antibi-
otics (30.7% more likely versus 34.5% less likely; p =
0.19) (Fig. 1a, b). Of respondents who believed antibi-
otics would ‘definitely/probably help’ and exposed to the
‘mild-fear-plus-empowerment’ message, significantly
more said they were more likely (rather than less likely)
to consult for ILI (149 (35.9%) more versus 114 (27.5%)
less; p = 0.03), but significantly more said they were less
likely (rather than more likely) to request antibiotics
(173 (41.7%) less versus 97 (23.4%) more; p < 0.0001)
(Fig. 2a, b).
The differences between responses to the ‘fear-only’
and ‘strong-fear-plus-empowerment’ messages were even
more pronounced than the differences between the
‘fear-only’ and ‘mild-fear-plus-empowerment’ messages.
Among those who found the ‘strong-fear-plus-empower-
ment’ message ‘very/somewhat new’, there was no sig-
nificant difference between the proportions who said
they would be more likely (versus less likely) to consult
(p = 0.85) and they were significantly less likely (rather
than more likely) to request antibiotics (182 (46.9%) less
versus 95 (24.5%) more; p < 0.0001) (Fig. 1a, b). Of re-
spondents who believed antibiotics would ‘definitely/
probably help’ and exposed to the ‘strong-fear-plus-em-
powerment’ message, significantly more said they were
less likely (rather than more likely) both to consult (159
(38.0%) less versus 121 (28.9%) more; p = 0.03) and to
request antibiotics (197 (47.1%) less versus 91 (21.8%)
more; p < 0.0001) (Fig. 2a, b).
Reported response to information for respondents’
children’s ILI
Overall, 496 (31.0%) of 1600 parents said the informa-
tion they were randomised to was ‘very/somewhat new’,
with no evidence of variation between messages (134/
408 (32.8%) ‘fear-only’, 169/587 (28.8%) ‘mild-fear-plus-
empowerment’, 193/605 (31.9%) ‘strong-fear-plus-em-
powerment’; p = 0.32, Additional file 2: Table S3). Fur-
thermore, 688 (43.0%) of parents believed antibiotics
would ‘definitely/probably’ help their child if they had an
ILI which persisted for 5 days, with no evidence of vari-
ation across messages (p = 0.52, Table 2). As above, and
as hypothesised, the outcomes depended strongly on
whether or not respondents found the information pro-
vided about AMR ‘very/somewhat new’ (both ‘visit doc-
tor’ and ‘ask for antibiotics’ interactions p < 0.0001) or
said they thought antibiotics would ‘definitely/probably’
help ILI (both ‘visit doctor’ and ‘ask for antibiotics’ inter-
actions p < 0.0001).
Overall results (Figs. 1c, d and 2c, d) were congruent
with those for respondents themselves (details in Add-
itional file 3). In brief, among parents for whom the in-
formation was not ‘very/somewhat new’ and who did
not think antibiotics would help their child’s ILI, signifi-
cantly more respondents said they would be less likely
(rather than more likely) to consult/request antibiotics
for their child’s ILI in response to each message (p <
0.001, Figs. 1c, d and 2c, d).
There were contrasting results among parents for
whom the information was ‘very/somewhat new’. Of par-
ents exposed to the ‘fear-only’ information, significantly
more of those for whom the information was ‘very/
somewhat new’ said they were more likely (rather than
less likely) to consult for their child’s ILI and request an-
tibiotics (p < 0.05) (Fig. 1c, d). Among parents exposed
to this information who believed antibiotics would ‘def-
initely/probably’ help their child, significantly more said
they were more likely (rather than less likely) to consult
for their child’s ILI (p < 0.0001) (Fig. 2c, d), with no
change in reported likelihood of requesting antibiotics
(p = 0.27). Among parents receiving the ‘mild-fear-plus-
empowerment’ message, significantly more of those for
whom the information was ‘very/somewhat new’ said
they were more likely (rather than less likely) to consult
for their child’s ILI and request antibiotics (p < 0.03).
Among parents exposed to this information who
thought antibiotics would ‘definitely/probably’ help, sig-
nificantly more said they were more likely (rather than
less likely) to consult for their child’s ILI (p < 0.0001),
with no change in reported likelihood of requesting anti-
biotics (p = 0.58). Among parents given the ‘strong-fear-
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plus-empowerment’ message, significantly more of those
for whom the information was ‘very/somewhat new’ said
they were more likely (rather than less likely) to consult
for their child’s ILI (p < 0.0001), but in contrast to the
other two randomised messages, they were not more
likely (versus less likely) to request antibiotics for their
child (31.1% more likely versus 37.8% less likely; p =
0.30). Moreover, parents given this message who thought
antibiotics would ‘definitely/probably’ help were not sig-
nificantly more likely (versus less likely) to consult for
their child’s ILI (31.6% more likely versus 24.4% less
likely; p = 0.06), and significantly more said they were
less likely (rather than more likely) to request antibiotics
for their child (40.4% less likely versus 24.0% more likely;
p = 0.003).
Discussion
In this study, we hypothesised that fear-based informa-
tional messages about AMR, intended to reduce consul-
tations and antibiotic requests for ILI, are more likely to
be effective, particularly among those with low AMR
awareness, if they contain empowering information
about successful self-management without antibiotics.
We examined this hypothesis by developing three fear-
based messages about AMR, with and without an em-
powerment element, and testing them in a randomised
survey experiment. The aim was to inform future public
campaigns intended to reduce antibiotic requests for ILI,
although our findings have broader application. We
found that for all the informational messages tested,
there were stark differences in how respondents said the
information would affect their future consultations and
antibiotic requests. The magnitude of these differences
depended on whether the information they were given
was new to them or whether they thought antibiotics
would help ILI. Those for whom the information was
not new (or who did not think antibiotics would help)
stated that the information was likely to make them less
likely to consult or request antibiotics, regardless of
which message they were given. This suggests that re-
peated campaigns may be important for re-educating
those who think they are already well informed about
appropriate antibiotic use. Crucially, however, where the
information was new, only those given the ‘strong-fear-
plus-empowerment’ message said they would be no
more likely to consult and less likely to request antibi-
otics. Those given the ‘mild-fear-plus-empowerment’
message were not significantly less likely to consult or
request antibiotics for ILI. This is consistent with the
most recent meta-analysis on fear-appeal messages
which found that in general, they are more effective
when relatively high fear levels are employed [23]. There
was no evidence that those given the ‘fear-only’ message
were less likely to request antibiotics for ILI, and
consistent with our previous work [24], they were more
likely to consult.
The key study limitation is that it relies on how survey
respondents claimed they would behave in response to
information. Reported intentions may differ from actual
behaviour. However, there is evidence from meta-
analyses that intentions predict infrequent, non-habitual
behaviours [25] and that changing behavioural intentions
engenders behaviour change [26]. Another limitation is
that only members of the online survey panel were eli-
gible. Thus, the sample was limited to those with an
interest in completing surveys, internet access, and basic
computer literacy. However, the use of this panel also
meant that age, gender, ethnicity, geographic region, and
employment status were broadly representative of the
general UK population, though the percentage with
higher education (44%) was higher than the population
average (27%).
Previously [24], we found that fear messages about
AMR could potentially backfire among respondents
poorly informed about AMR. There, those who found a
‘fear-only’ message (almost identical to version 1) ‘very/
somewhat surprising’ said they were more likely to con-
sult and to request antibiotics for ILI. Based on evidence
from behavioural science [21–23], we hypothesised that
the unintended response to this information may be be-
cause the original message lacked empowering informa-
tion about effective self-management of ILI without
antibiotics. A major study strength is that this insight
from behavioural science was used, apparently success-
fully, to develop informational messages likely not only
to avoid backfiring, but to effectively reduce antibiotic
requests for ILI. With just minor changes to wording,
this study also attempted, and broadly succeeded, in rep-
licating the results reported in our previous work [24],
by testing a ‘fear-only’ message (included in Figs. 1 and 2
as ‘Prior Survey’ to facilitate comparability).
To address the limitation that the respondents for
whom information was ‘very/somewhat new’ varied
across the three versions tested, in our exploratory ana-
lysis, we also disaggregated respondents according to be-
liefs about antibiotic effectiveness for ILI, rather than
how new the information provided was. Using this com-
mon indicator, which did not vary across randomisa-
tions, provided similar results.
While here we developed and tested fear messages
intended to improve thinking and behaviour about anti-
biotic use, the phenomenon we studied is widely preva-
lent. Meta-analyses [21–23] have identified the
importance, generally, in fear campaigns of including
empowering messages that the ‘call-to-action’ is rela-
tively easy, and will be effective in mitigating the danger
referred to. This is the first study to explicitly apply and
test this finding in the context of fear messages about
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AMR. Our results strongly suggest that this general
point is highly relevant to the development of public
campaigns warning of the dangers of AMR, and support
its importance more generally in campaigns.
We found that a ‘strong-fear-plus-empowerment’ mes-
sage was likely to be effective at reducing both consulta-
tions and requests for antibiotics among adults.
However, even this relatively successful version was
likely to lead to increased consultation for children with
ILI. The overall effect on requests for children was not
consistent, with those who believed antibiotics would
help their child’s ILI being more likely to take their child
to a doctor, but less likely to request antibiotics if they
went. It is possible that our self-care advice (plenty of
fluids and sleep, or to take paracetamol) may be per-
ceived as difficult to implement, or too generic [27], by
parents of young children, and they may feel they re-
quire advice from a primary care physician about
management.
Children account for a large proportion of antibiotics
taken for ILI, and the factors which affect consulting
and prescribing are not the same as for adults. More re-
search is needed on developing informational messages
for parents that could safely and effectively reduce un-
necessary prescribing for ILI in children by reducing
consultations and antibiotic requests. More broadly, fu-
ture research could test fear messages which vary with
regard to the nature of the empowerment content
employed, incorporating respondent self-efficacy and
response-efficacy elements via different forms of word-
ing. Future research should also address whether the
hypothetical future behaviour our respondents reported
in response to our informational messages can be repli-
cated in studies testing actual behaviour. In particular, it
would be valuable to design a randomised trial to test
the effect of the provision of informational messages,
such as those developed here, on more objective mea-
sures of antibiotic use. It may also be valuable to investi-
gate the long-term effects of such messages, as these
could differ from the short-term effects. It is conceiv-
able, for example, that repeated exposure to even the
least effective message in this study could ultimately
have positive long-term effects by improving AMR
awareness over time and thereby making respondents
more likely to respond favourably to future messages.
More generally, our results emphasise the importance of
testing any proposed public antibiotic-stewardship cam-
paigns before they are rolled out to wide audiences.
Conclusion
This study developed and tested, using a randomised de-
sign, fear-based messages about antibiotics and AMR,
both with and without empowering information that
influenza-like symptoms are self-limiting and can easily
be self-managed, e.g. with paracetamol, rest, and fluids.
Consistent with meta-analyses on the effectiveness of
fear-based messages in other healthcare areas, the evi-
dence from this study suggests that fear-based messages
about antibiotics and AMR are more likely to be effect-
ive in reducing consultations and antibiotic requests, es-
pecially among those with low AMR awareness, if they
include ‘empowering’ information about effective self-
management without antibiotics.
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